US2013122084A1PendingUtilityA1

Hydrogel

Assignee: EURO CELTIQUE SAPriority: Feb 2, 2006Filed: Jan 3, 2013Published: May 16, 2013
Est. expiryFeb 2, 2026(expired)· nominal 20-yr term from priority
A61P 31/04A61P 31/00A61P 43/00A61L 15/44A61L 26/008A61P 17/02A61L 15/24A61L 26/0014
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention is related to gel preparations capable of absorbing as well as releasing liquid, and the use of such gel preparations in the treatment of wounds.

Claims

exact text as granted — not AI-modified
1 - 46 . (canceled) 
     
     
         47 . A preparation for wound healing comprising a hydrogel comprising 1-3% by weight of a polymer complying with the USP Carbomer 940 series and water, said hydrogel having a pH value in the range of 4 to 6.5, wherein the capability of the preparation to release liquid is greater than its capability to absorb liquid when applied to a wound, as measured under conditions in accordance with EN 13726-1:2002. ; the preparation does not contain liposomes and iodine; and the preparation comprises a polymer complying with the USP Carbomer 940 series, wherein the hydrogel has a pH value in the range of 4 to 6.5. 
     
     
         48 . The preparation according to  claim 47 , wherein the preparation further comprises one or more additives selected from the group consisting of adjuvants, conserving agents, antioxidants, consistency forming additives and pH-adjusting agents. 
     
     
         49 . The preparation according to  claim 47 , wherein the preparation absorbs liquid absorption of the hydrogel is less than 8% liquid, as tested in accordance with EN 13726-1:2002. 
     
     
         50 . The preparation according to  claim 47 , wherein the preparation absorbs liquid absorption of the hydrogel is less than 15% liquid, as tested in accordance with EN 13726-1:2002. 
     
     
         51 . A wound dressing comprising a preparation according to  claim 47 . 
     
     
         52 . A method for treating a wound, wherein said method comprises administering, to the wound, a hydrogel preparation for wound healing according to  claim 47  comprising a polymer complying with the USP Carbomer 940 series; wherein the hydrogel has a pH value in the range of 4 to 6.5; the capability of the hydrogel to release liquid is greater than its capability to absorb liquid; and the hydrogel preparation does not include a liposome. 
     
     
         53 . The preparation according to  claim 47 , further comprising at least one antiseptic agent. 
     
     
         54 . The preparation according to  claim 53 , wherein the antiseptic agent comprises at least one compound selected from the group consisting of oxygen- and halogen-releasing compounds and metal compounds. 
     
     
         55 . The preparation according to  claim 54 , wherein the antiseptic agent is an iodine complex. 
     
     
         56 . The preparation according to  claim 55 , wherein the iodine complex is PVP-iodine. 
     
     
         57 . The preparation according to  claim 56 , further comprising liposomes. 
     
     
         58 . The preparation according to  claim 57 , wherein the liposomes are phospholipid-based liposomes. 
     
     
         59 . The preparation according to  claim 47 , further comprising a wound-healing promoting agent. 
     
     
         60 . The preparation according to  claim 47 , wherein said preparation is free of liposomes. 
     
     
         61 . The preparation according to  claim 47 , wherein the polymer is Carbopol 980NF. 
     
     
         62 . The preparation according to  claim 47 , wherein the pH is in the range of 5 to 6. 
     
     
         63 . A wound dressing comprising a hydrogel comprising 1-3% by weight of a polymer complying with the USP Carbomer 940 series and water, said hydrogel having a pH value in the range of 4 to 6.5. 
     
     
         64 . The wound dressing of  claim 63 , wherein the polymer is Carbopol 980NF. 
     
     
         65 . The wound dressing according to  claim 63 , further comprising a film forming substance. 
     
     
         66 . The wound dressing according to  claim 63 , further comprising at least one antiseptic agent. 
     
     
         67 . The wound dressing according to  claim 66 , wherein the antiseptic agent comprises at least one compound selected from the group consisting of oxygen- and halogen-releasing compounds and metal compounds.

Join the waitlist — get patent alerts

Track US2013122084A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.